ETST logo

Earth Science Tech, Inc. (ETST) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

ETST steht fuer Earth Science Tech, Inc., ein Healthcare-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Die Aktie erzielt 61/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.

Zuletzt analysiert: 17. März 2026
61/100 KI-Bewertung

Earth Science Tech, Inc. (ETST) Gesundheitswesen & Pipeline-Uebersicht

CEOGiorgio R. Saumat
Mitarbeiter32
HauptsitzMiami, US
IPO-Jahr2014

Earth Science Tech, Inc. operates in the healthcare sector, focusing on nutraceuticals and dietary supplements for various health conditions. With a market capitalization of $0.03 billion and a P/E ratio of 9.88, the company distributes its products through retail, clinics, pharmacies, and online channels, competing in a fragmented market.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

Earth Science Tech, Inc. presents a speculative investment opportunity within the nutraceutical and dietary supplement market. With a market capitalization of $0.03 billion and a P/E ratio of 9.88, the company's valuation reflects both its growth potential and inherent risks associated with OTC-listed companies. A gross margin of 65.1% indicates strong pricing power, while a profit margin of 10.0% demonstrates profitability. Growth catalysts include expanding its online presence and developing new formulations for existing products. However, potential risks include the company's reliance on a limited product line and the competitive nature of the nutraceutical market. The company's high beta of 2.02 suggests significant volatility, making it suitable for investors with a high-risk tolerance. The lack of dividend yield further emphasizes its growth-oriented profile.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $0.03 billion indicates a small-cap company with potential for growth but also higher risk.
  • P/E ratio of 9.88 suggests the company is potentially undervalued compared to its earnings.
  • Gross margin of 65.1% reflects strong pricing power and efficient cost management.
  • Profit margin of 10.0% demonstrates the company's ability to generate profit after all expenses.
  • Beta of 2.02 indicates high volatility compared to the market, suggesting higher risk and potential reward.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Diverse product line targeting various health conditions.
  • Multi-channel distribution network.
  • Strong gross margin indicating pricing power.
  • Focus on natural and alternative health solutions.

Schwaechen

  • Small market capitalization and limited financial resources.
  • High beta indicating significant volatility.
  • Reliance on a limited number of key products.
  • Limited brand recognition compared to larger competitors.

Katalysatoren

  • Upcoming: Potential new product launches in the nutraceutical and dietary supplement market.
  • Ongoing: Expansion of online presence and e-commerce sales channels.
  • Ongoing: Strategic partnerships with clinics, pharmacies, and healthcare providers.

Risiken

  • Potential: Intense competition from larger and more established companies in the nutraceutical industry.
  • Potential: Changing regulations and compliance requirements affecting the dietary supplement market.
  • Potential: Fluctuations in raw material prices impacting the company's profitability.
  • Ongoing: Limited financial resources and small market capitalization.
  • Ongoing: High beta indicating significant price volatility.

Wachstumschancen

  • Expanding Online Presence: ETST can capitalize on the growing e-commerce trend by enhancing its online platform and digital marketing efforts. The global e-commerce market is projected to reach trillions of dollars in the coming years, offering a significant opportunity for ETST to increase its sales and market reach. By investing in SEO, social media marketing, and targeted advertising, ETST can attract new customers and drive online sales, with an expected impact within the next 1-2 years.
  • Developing New Formulations: ETST can invest in research and development to create new and innovative formulations for its existing products. The nutraceutical industry is constantly evolving, with new ingredients and delivery methods emerging regularly. By staying ahead of the curve and developing unique and effective formulations, ETST can differentiate itself from competitors and attract health-conscious consumers. This could lead to new product launches within the next 18-24 months.
  • Strategic Partnerships: ETST can form strategic partnerships with clinics, pharmacies, and healthcare providers to expand its distribution network and reach a wider audience. Collaborating with established healthcare professionals can enhance ETST's credibility and build trust with consumers. These partnerships could be established within the next year, leading to increased sales and market penetration.
  • Geographic Expansion: ETST can explore opportunities to expand its operations into new geographic markets, particularly in regions with a growing demand for nutraceuticals and dietary supplements. Emerging markets in Asia and Latin America offer significant growth potential. By conducting market research and adapting its products to local preferences, ETST can successfully enter new markets and diversify its revenue streams over the next 2-3 years.
  • Focus on Specific Health Conditions: ETST can focus its marketing efforts on specific health conditions, such as chronic pain, joint pain, and inflammation. By targeting consumers with specific health needs, ETST can increase its brand awareness and build a loyal customer base. This targeted approach can be implemented within the next 6-12 months, leading to improved marketing ROI and increased sales.

Chancen

  • Expanding online presence and e-commerce sales.
  • Developing new and innovative product formulations.
  • Forming strategic partnerships with healthcare providers.
  • Entering new geographic markets with growing demand for nutraceuticals.

Risiken

  • Intense competition from larger and more established companies.
  • Changing regulations and compliance requirements.
  • Fluctuations in raw material prices.
  • Negative publicity or adverse events affecting the nutraceutical industry.

Wettbewerbsvorteile

  • Proprietary formulations and unique product offerings.
  • Established distribution network through multiple channels.
  • Brand recognition and customer loyalty in specific market segments.

Ueber ETST

Earth Science Tech, Inc. (ETST) is a biotechnology company that develops, markets, and distributes nutraceuticals, bioceuticals, and dietary supplements. Founded in 2010 and formerly known as Ultimate Novelty Sports, Inc., the company rebranded in March 2014 to focus on health and wellness products. Headquartered in Doral, Florida, ETST offers a range of products targeting chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. The company's product portfolio includes hemp oils, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. These are available in various formulations such as capsules, tablets, soft gels, chewables, liquids, creams, sprays, and powders. ETST distributes its products through multiple channels, including its retail store, clinics, pharmacies, and online platforms. This multi-channel approach aims to maximize market reach and cater to diverse customer preferences. ETST also provides medical equipment and devices, further diversifying its offerings within the healthcare sector. The company operates with 32 employees and aims to expand its market presence through innovative product development and strategic distribution partnerships.

Was das Unternehmen tut

  • Develops and markets nutraceuticals and bioceuticals.
  • Offers dietary supplements for various health conditions.
  • Provides products targeting chronic pain, joint pain, and inflammation.
  • Distributes hemp oils, vitamins, minerals, and herbs.
  • Sells personal care products, homeopathies, and functional foods.
  • Offers medical equipment and devices.

Geschaeftsmodell

  • Develops and manufactures nutraceutical and dietary supplement products.
  • Distributes products through retail stores, clinics, pharmacies, and online channels.
  • Generates revenue through the sale of its products to consumers and healthcare providers.

Branchenkontext

Earth Science Tech, Inc. operates within the growing nutraceutical and dietary supplement industry. This market is characterized by increasing consumer awareness of health and wellness, driving demand for natural and alternative health solutions. The industry is highly competitive, with numerous players ranging from large pharmaceutical companies to smaller, specialized firms. ETST competes with companies offering similar products, focusing on specific health conditions and distribution channels. The global nutraceutical market is expected to continue growing, driven by aging populations and rising healthcare costs.

Wichtige Kunden

  • Individuals seeking natural health and wellness solutions.
  • Patients with chronic pain, joint pain, and inflammation.
  • Healthcare providers recommending supplements to their patients.
  • Consumers interested in vitamins, minerals, and herbal remedies.
KI-Zuversicht: 69% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

Earth Science Tech, Inc. (ETST) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ETST.

Kursziele

Wall-Street-Kurszielanalyse fuer ETST.

MoonshotScore

61/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von ETST auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Giorgio R. Saumat

CEO

Giorgio R. Saumat serves as the Chief Executive Officer of Earth Science Tech, Inc. His background includes experience in managing and growing businesses, with a focus on strategic planning and operational efficiency. He is responsible for overseeing the company's overall strategy, product development, and market expansion efforts. His leadership aims to drive innovation and growth within the nutraceutical and dietary supplement market.

Erfolgsbilanz: Under Giorgio R. Saumat's leadership, Earth Science Tech, Inc. has focused on expanding its product line and distribution channels. Key achievements include the development of new formulations and the establishment of strategic partnerships. His tenure has been marked by efforts to increase brand awareness and market penetration within the competitive nutraceutical industry.

ETST OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that Earth Science Tech, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: As an OTC-listed stock, ETST likely experiences lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at desired prices. The limited liquidity may also contribute to increased price volatility and potential for manipulation.
OTC-Risikofaktoren:
  • Limited financial disclosure and transparency.
  • Lower trading volumes and liquidity.
  • Greater price volatility and potential for manipulation.
  • Higher risk of fraud or mismanagement.
  • Limited regulatory oversight and investor protection.
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's OTC Markets profile and disclosure history.
  • Check for any regulatory actions or legal proceedings involving the company.
  • Consult with a qualified financial advisor before investing.
  • Understand the risks associated with investing in OTC stocks.
Legitimitaetssignale:
  • Company has been in operation since 2010.
  • Company has a diverse product line targeting various health conditions.
  • Company distributes products through multiple channels, including retail stores and online platforms.

Haeufige Fragen zu ETST

What are the key factors to evaluate for ETST?

Earth Science Tech, Inc. (ETST) currently holds an AI score of 61/100, indicating moderate score. Key strength: Diverse product line targeting various health conditions.. Primary risk to monitor: Potential: Intense competition from larger and more established companies in the nutraceutical industry.. This is not financial advice.

How frequently does ETST data refresh on this page?

ETST prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ETST's recent stock price performance?

Recent price movement in Earth Science Tech, Inc. (ETST) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse product line targeting various health conditions.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider ETST overvalued or undervalued right now?

Determining whether Earth Science Tech, Inc. (ETST) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying ETST?

Before investing in Earth Science Tech, Inc. (ETST), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding ETST to a portfolio?

Potential reasons to consider Earth Science Tech, Inc. (ETST) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diverse product line targeting various health conditions.. Additionally: Multi-channel distribution network.. The AI-driven MoonshotScore of 61/100 reflects solid quantitative fundamentals. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of ETST?

Yes, most major brokerages offer fractional shares of Earth Science Tech, Inc. (ETST) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track ETST's earnings and financial reports?

Earth Science Tech, Inc. (ETST) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ETST earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Information is based on available data and may be subject to change.
  • OTC market data may be less reliable than data from major exchanges.
Datenquellen

Popular Stocks